Tumour avatars to model patients' responses to immunotherapy
Nat Rev Cancer
.
2022 Dec;22(12):660.
doi: 10.1038/s41568-022-00517-7.
Author
Daniela S Thommen
1
Affiliation
1
Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.thommen@nki.nl.
PMID:
36167841
DOI:
10.1038/s41568-022-00517-7
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunologic Factors
Immunotherapy*
Neoplasms* / therapy
Substances
Immunologic Factors